103 related articles for article (PubMed ID: 2319129)
21. In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment.
Nag B; Passmore D; Deshpande SV; Clark BR
J Immunol; 1992 Jan; 148(2):369-72. PubMed ID: 1370312
[TBL] [Abstract][Full Text] [Related]
22. Immunodominance does not result from peptide competition for MHC class II presentation.
Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
[TBL] [Abstract][Full Text] [Related]
23. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
24. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo.
Nikcevich KM; Kopielski D; Finnegan A
J Immunol; 1994 Aug; 153(3):1015-26. PubMed ID: 7517970
[TBL] [Abstract][Full Text] [Related]
25. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes.
Ramachandra L; Song R; Harding CV
J Immunol; 1999 Mar; 162(6):3263-72. PubMed ID: 10092778
[TBL] [Abstract][Full Text] [Related]
26. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
Adorini L; Ullrich SJ; Appella E; Fuchs S
Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
[TBL] [Abstract][Full Text] [Related]
27. Structural analysis of the interaction of apamin with Ia and its recognition by Ad- or Ab-restricted mouse T cells.
Regnier-Vigouroux A; Ceard B; Van Rietschoten J; Granier C; Pierres M
J Immunol; 1989 Nov; 143(10):3167-74. PubMed ID: 2478620
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.
Wauben MH; Joosten I; Schlief A; van der Zee R; Boog CJ; van Eden W
J Immunol; 1994 Apr; 152(8):4211-20. PubMed ID: 7511673
[TBL] [Abstract][Full Text] [Related]
29. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules.
Harris DP; Vordermeier HM; Arya A; Moreno C; Ivanyi J
Immunology; 1995 Apr; 84(4):555-61. PubMed ID: 7790029
[TBL] [Abstract][Full Text] [Related]
30. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.
Davis CB; Mitchell DJ; Wraith DC; Todd JA; Zamvil SS; McDevitt HO; Steinman L; Jones PP
J Immunol; 1989 Oct; 143(7):2083-93. PubMed ID: 2476496
[TBL] [Abstract][Full Text] [Related]
31. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
[TBL] [Abstract][Full Text] [Related]
32. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors.
Vidard L; Rock KL; Benacerraf B
J Immunol; 1991 Sep; 147(6):1786-91. PubMed ID: 1890304
[TBL] [Abstract][Full Text] [Related]
33. Structural analysis of peptides capable of binding to more than one Ia antigen.
Sette A; Buus S; Colon S; Miles C; Grey HM
J Immunol; 1989 Jan; 142(1):35-40. PubMed ID: 2535860
[TBL] [Abstract][Full Text] [Related]
34. Inefficient peptide binding by cell-surface class II MHC molecules.
Sherman MA; Weber DA; Spotts EA; Moore JC; Jensen PE
Cell Immunol; 1997 Nov; 182(1):1-11. PubMed ID: 9427804
[TBL] [Abstract][Full Text] [Related]
35. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162.
Oshima M; Atassi MZ
J Immunol; 1995 May; 154(10):5245-54. PubMed ID: 7537303
[TBL] [Abstract][Full Text] [Related]
36. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
Guéry JC; Sette A; Appella E; Adorini L
J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
38. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens.
Rott O; Tontsch U; Fleischer B
J Immunol; 1993 Jan; 150(1):87-95. PubMed ID: 7678036
[TBL] [Abstract][Full Text] [Related]
39. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells.
Shastri N; Gonzalez F
J Immunol; 1993 Apr; 150(7):2724-36. PubMed ID: 8454852
[TBL] [Abstract][Full Text] [Related]
40. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
Singh N; Van Kaer L
J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
